Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 1225Terminated 332Unknown 318Recruiting 318Active not recruiting 180Withdrawn 96Not yet recruiting 88Suspended 7Enrolling by invitation 3Temporarily not available 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1

Conditions

Muscle Invasive Bladder Urothelial Carcinoma 1Lymphatic Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Gemcitabine × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Enrolling by invitation
12 enrolled

Lymphatic Metastasis

NCT06883136 2025-03-19

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Qianfoshan Hospital

Enrolling by invitation
43 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡